Latest & greatest articles for lithium

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on lithium or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on lithium and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for lithium

1. Lithium

Lithium Top results for lithium - Trip Database or use your Google+ account Liberating the literature My query is: English Français Deutsch Čeština Español Magyar Svenska ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search (...) button. An example search might look like (#1 or #2) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for lithium The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory

Trip Latest and Greatest2018

3. Lithium Use in Pregnancy and the Risk of Cardiac Malformations.

Lithium Use in Pregnancy and the Risk of Cardiac Malformations. Background There has been concern that exposure to lithium early in pregnancy may be associated with a marked increase in the risk of Ebstein's anomaly (a right ventricular outflow tract obstruction defect) in infants and overall congenital cardiac defects, but data are conflicting and limited. Methods We conducted a cohort study involving 1,325,563 pregnancies in women who were enrolled in Medicaid and who delivered a live-born (...) infant between 2000 and 2010. We examined the risk of cardiac malformations among infants exposed to lithium during the first trimester as compared with unexposed infants and, in secondary analyses, with infants exposed to another commonly used mood stabilizer, lamotrigine. Risk ratios and 95% confidence intervals were estimated with control for psychiatric and medical conditions, medications, and other potential confounders. Results Cardiac malformations were present in 16 of the 663 infants exposed

NEJM2017

4. Lithium disilicate single crowns demonstrate favorable clinical outcomes in 1 through 5 years compared with lithium disilicate fixed prostheses

Lithium disilicate single crowns demonstrate favorable clinical outcomes in 1 through 5 years compared with lithium disilicate fixed prostheses Lithium disilicate single crowns demonstrate favorable clinical outcomes in 1 through 5 years compared with lithium disilicate fixed prostheses ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Take advantage of endorsed, discounted business products Access cutting-edge continuing education courses Find evidence (...) and resources for children's oral health Visit the Ad Council's children's oral health website Evidence Education About * Associated Topics Lithium disilicate single crowns demonstrate favorable clinical outcomes in 1 through 5 years compared with lithium disilicate fixed prostheses Julie M. Coe, DDS, MS, MBA . Overview Systematic Review Conclusion Lithium disilicate (LD) single crowns indicated excellent outcome in 1 through 5 years (5-year cumulative survival, 97.8%) compared with LD fixed prostheses

ADA Center for Evidence-Based Dentistry2017

5. Lithium disilicate single crowns demonstrate favorable clinical outcomes in 1 through 5 years compared with lithium disilicate fixed prostheses

Lithium disilicate single crowns demonstrate favorable clinical outcomes in 1 through 5 years compared with lithium disilicate fixed prostheses Lithium disilicate single crowns demonstrate favorable clinical outcomes in 1 through 5 years compared with lithium disilicate fixed prostheses ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice (...) and resources for children's oral health Visit the Ad Council's children's oral health website Evidence Education About * Associated Topics Lithium disilicate single crowns demonstrate favorable clinical outcomes in 1 through 5 years compared with lithium disilicate fixed prostheses Julie M. Coe, DDS, MS, MBA . Overview Systematic Review Conclusion Lithium disilicate (LD) single crowns indicated excellent outcome in 1 through 5 years (5-year cumulative survival, 97.8%) compared with LD fixed prostheses

ADA Center for Evidence-Based Dentistry2017

7. Use of lithium and cancer risk in patients with bipolar disorder: population-based cohort study

Use of lithium and cancer risk in patients with bipolar disorder: population-based cohort study 27388574 2016 07 08 2016 11 03 1472-1465 209 5 2016 Nov The British journal of psychiatry : the journal of mental science Br J Psychiatry Use of lithium and cancer risk in patients with bipolar disorder: population-based cohort study. 393-399 Lithium inhibits glycogen synthase kinase-3, which is an enzyme involved in the pathogenesis of cancer. To investigate the association between lithium (...) and cancer risk in patients with bipolar disorder. A retrospective cohort study was designed using the National Health Insurance Research Database (NHIRD) in Taiwan. Patients using lithium comprised the index drug group and patients using anticonvulsants only comprised the control group. Time-dependent Cox regression was used to evaluate the hazard ratios (HRs) for risk of cancer. Compared with anticonvulsant-only exposure, lithium exposure was associated with significantly lower cancer risk (HR = 0.735

EvidenceUpdates2016

8. Outcomes: Reconsidering risk factors for renal dysfunction in lithium-treated patients

Outcomes: Reconsidering risk factors for renal dysfunction in lithium-treated patients Reconsidering risk factors for renal dysfunction in lithium-treated patients | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu (...) Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Reconsidering risk factors for renal dysfunction in lithium-treated patients Article Text Further commentaries Electronic pages Outcomes Reconsidering risk factors for renal dysfunction in lithium-treated patients Alberto Bocchetta Correspondence to Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy; bocchett

Evidence-Based Mental Health2016

9. Hemodialysis for lithium poisoning.

Hemodialysis for lithium poisoning. BACKGROUND: Lithium salts, particularly lithium carbonate, are frequently used to treat bipolar disorder and mania. Lithium poisoning, which can occur as a result of reduced renal elimination, prescribing error, drug-drug interactions, or deliberate overdosage, produces neurologic injury that can be permanent. Hemodialysis is often recommended to treat lithium poisoning. Although hemodialysis clearly enhances the elimination of lithium, it is unclear whether (...) this translates into improved patient outcomes. Evidence from observational studies, generally of low methodological quality, shows similar outcomes in patients managed with or without the use of hemodialysis. OBJECTIVES: To determine whether hemodialysis, applied in addition to standard therapy, reduces the likelihood, severity, or duration of neurological sequelae following lithium poisoning. SEARCH METHODS: We ran the search on 15 May 2015. We searched the Cochrane Injuries Group's Specialised Register

Cochrane2015

10. Lithium for bipolar disorder: prevent adverse effects

Lithium for bipolar disorder: prevent adverse effects Prescrire IN ENGLISH - Spotlight ''Lithium for bipolar disorder: prevent adverse effects '', 1 March 2014 {1} {1} {1} | | > > > Lithium for bipolar disorder: prevent adverse effects Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight Lithium for bipolar disorder: prevent adverse effects Lithium (...) is the reference drug for stabilising the mood of patients suffering from bipolar disorder. But it needs to be carefully dosed since there is a very narrow margin between the therapeutic dose and the appearance of sometimes severe adverse effects. With careful adjustment of the dosage the risk of adverse effects remains low. Lithium is a reference drug for stabilising the mood of patients suffering from bipolar disorders and preventing acute suicidal and manic episodes. But there is a fine line – a narrow

Prescrire2014

11. Lithium

Lithium USE OF LITHIUM IN PREGNANCY 0344 892 0909 USE OF LITHIUM IN PREGNANCY (Date of issue: May 2015 , Version: 2 ) This is a UKTIS monograph for use by health care professionals. For case-specific advice please contact UKTIS on 0344 892 0909. To report an exposure please download and complete a . Please encourage all women to complete an . A corresponding patient information leaflet on is available at . Summary Lithium is a mood stabilising agent licensed for the treatment and prophylaxis (...) of mania, bipolar disorder and recurrent depression, and the treatment of aggressive or mutilating behaviour. Lithium levels need to be monitored regularly in the non-pregnant patient and more frequently throughout pregnancy and the postnatal period. The majority of studies have not suggested an overall increased risk of congenital malformation, although a possible increased risk of cardiac defects has been found. An early retrospective study suggested an association between in utero lithium exposure

UK Teratology Information Service2014

12. Need exists for genetic predictors of lithium response

Need exists for genetic predictors of lithium response Need exists for genetic predictors of lithium response | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal (...) accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Need exists for genetic predictors of lithium response Article Text Causes and risk factors Need exists for genetic predictors of lithium response James B Potash 1 , Thomas G Schulze 2 Statistics from Altmetric.com No Altmetric data available for this article. What is already known on this topic? Patients with bipolar disorder respond differentially to lithium; some predictors of good response

Evidence-Based Mental Health2014

13. Lithium or an atypical antipsychotic drug in the management of treatment resistant depression: a systematic review and economic evaluation

Lithium or an atypical antipsychotic drug in the management of treatment resistant depression: a systematic review and economic evaluation Lithium or an atypical antipsychotic drug in the management of treatment resistant depression: a systematic review and economic evaluation Journals Library An error has occurred in processing the XML document An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could

NIHR HTA programme2013

14. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis

Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis Cipriani A, Hawton K, Stockton S, Geddes JR CRD summary This updated review concluded that lithium was effective in reducing the risk of suicide in people with mood disorders such as depression (...) and bipolar disorder. The conclusion reflects the evidence presented and is likely to be reliable. Authors' objectives To update a previous review that assessed the effectiveness of lithium in preventing suicide and self harm in people with mood disorders. Searching MEDLINE, EMBASE, CINAHL, PsycINFO, LILACS and Cochrane Central Register of Controlled Trials (CENTRAL) were searched from inception to January 2013. Search terms were reported. No language restrictions were applied. Trial databases

DARE.2013

15. Lithium Treatment Moderate-Dose Use Study (LiTMUS) for Bipolar Disorder: A Randomized Comparative Effectiveness Trial of Optimized Personalized Treatment With and Without Lithium

Lithium Treatment Moderate-Dose Use Study (LiTMUS) for Bipolar Disorder: A Randomized Comparative Effectiveness Trial of Optimized Personalized Treatment With and Without Lithium 23288387 2013 01 04 2013 02 19 2015 11 19 1535-7228 170 1 2013 Jan The American journal of psychiatry Am J Psychiatry Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. 102-10 10.1176 (...) /appi.ajp.2012.12060751 Lithium salts, once the mainstay of therapy for bipolar disorder, have tolerability issues at a higher dosage that often limit adherence. The authors investigated the comparative effectiveness of more tolerable dosages of lithium as part of optimized personalized treatment (OPT). The authors randomly assigned 283 bipolar disorder outpatients to 6 months of open, flexible, moderate dosages of lithium plus OPT or to 6 months of OPT alone. The primary outcome measures were

EvidenceUpdates2013

16. Lithium Disilicate Porcelain Is Weaker Than Zirconia When Comparing Fracture Toughness Of Dental Crowns

Lithium Disilicate Porcelain Is Weaker Than Zirconia When Comparing Fracture Toughness Of Dental Crowns UTCAT2417, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Lithium Disilicate Porcelain Is Weaker Than Zirconia When Comparing Fracture Toughness Of Dental Crowns Clinical Question In a 40 year old patient, how does lithium disilicate porcelain compare to zirconia in fracture toughness of dental crowns? Clinical (...) Bottom Line When comparing fracture toughness of dental crowns, zirconia is stronger than lithium disilicate crowns. In all studies, zirconia exhibited a higher fracture load and flexural strength than lithium disilicate. Best Evidence (you may view more info by clicking on the PubMed ID link) PubMed ID Author / Year Patient Group Study type (level of evidence) #1) Tinschert/2001 Three-unit FPDs In vitro study Key results FPDs of DC-Zirkon exhibited the highest fracture load (>2000N) while IPS

UTHSCSA Dental School CAT Library2013

17. Review: Lithium is associated with adverse events in patients with mood disorders.

Review: Lithium is associated with adverse events in patients with mood disorders. ACP Journal Club. Review: lithium is associated with adverse events in patients with mood disorders. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create (...) File 1 selected item: 22801701 Format MeSH and Other Data E-mail Subject Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2012 Jul 17;157(2):JC2-10. doi: 10.7326/0003-4819-157-2-201207170-02010. ACP Journal Club. Review: lithium is associated with adverse events in patients with mood disorders. . Comment on [Lancet. 2012] PMID: 22801701 DOI: Publication type Full Text

Annals of Internal Medicine2012

18. Lithium toxicity profile: a systematic review and meta-analysis

Lithium toxicity profile: a systematic review and meta-analysis Lithium toxicity profile: a systematic review and meta-analysis Lithium toxicity profile: a systematic review and meta-analysis McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR CRD summary This review explored harmful effects of lithium in patients with mood disorders. The authors concluded that increased risks of reduced urinary concentrating ability, hypothyroidism, hyperparathyroidism and weight gain were (...) possible without significant impact on renal function. Potential error and bias in the review process and concerns about the quality and synthesis of studies mean that this conclusion might not be reliable. Authors' objectives To assess the evidence for potentially harmful effects of lithium in patients with mood disorders. Searching MEDLINE, MEDLINE In-Process and Other Non-Indexed Citations, EMBASE, CINAHL, PsycINFO, The Cochrane Library, BIOSIS Previews and TOXNET were searched without language

DARE.2012

19. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial.

Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. 21525519 2011 04 28 2011 07 21 2017 02 03 1472-1465 198 5 2011 May The British journal of psychiatry : the journal of mental science Br J Psychiatry Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. 351-6 10.1192/bjp.bp.110.080044 Two recent clinical studies support the feasibility (...) of trials to evaluate the disease-modifying properties of lithium in Alzheimer's disease, although no benefits were obtained from short-term treatment. To evaluate the effect of long-term lithium treatment on cognitive and biological outcomes in people with amnestic mild cognitive impairment (aMCI). Forty-five participants with aMCI were randomised to receive lithium (0.25-0.5 mmol/l) (n = 24) or placebo (n = 21) in a 12-month, double-blind trial. Primary outcome measures were the modification

EvidenceUpdates2011

20. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study

Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study 20360317 2010 07 02 2010 07 22 2016 12 15 1535-7228 167 7 2010 Jul The American journal of psychiatry Am J Psychiatry Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. 792-800 10.1176/appi.ajp.2009.09020284 The authors examined the safety (...) and efficacy of long-term fluoxetine monotherapy, lithium monotherapy, and placebo therapy in preventing relapse and recurrence of bipolar type II major depressive episode. The authors hypothesized that fluoxetine monotherapy would be superior to lithium monotherapy with a similar hypomanic mood conversion rate. Patients at least 18 years old who recovered from their major depressive episode during initial open-label fluoxetine monotherapy were randomly assigned to receive 50 weeks of double-blind

EvidenceUpdates2010 Full Text: Link to full Text with Trip Pro